kras mutation and glutathion Targeting KRAS: from metabolic regulation to cancer treatment | Molecular Cancer KRAS Screening and Profiling Services
KRAS Screening and Profiling Services Overcoming resistance to drugs targeting KRASG12C mutation What should we know about the 'undruggable' target KRAS? MedChemExpress Research advances in the treatment of KRAS mutant colorectal cancer from Prof. Guoquan Gao's group at Zhongshan School of Medicine SUN YAT SEN UNIVERSITY kras mutation and glutathion glynac Interplays of glucose metabolism in pancreatic ductal adenocarcinoma GlyNAC Supplementation Improves Glutathione Deficiency, Promising direction for the treatment of pancreatic cancers driven by KRAS mutation Der Lab
Pay in 4 interest-free payments of $6.66 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29





